Oncology and Hematology - Prova Education

65-80 of 226

NSCLC Data Review: Efficacy and Safety Data for ON-State RAS Inhibitors
NSCLC Data Review: Efficacy and Safety Data for ON-State RAS Inhibitors
MinuteCE®
NSCLC Data Review: Efficacy and Safety Data for ON-State RAS Inhibitors
Kathryn Arbour
0.75 program credits
- Kathryn Arbour
0.75 program credits
MinuteCE®
The New Era of RAS Targeting: Mechanisms, Evidence, and Clinical Integration of ON-State Inhibitors
Kathryn Arbour; Eileen M. O'Reilly, MD
0.75 credits 8 episodes
- Kathryn Arbour
- Eileen M. O'Reilly, MD
0.75 credits 8 episodes
RAS Across Tumors: Who to Test When
RAS Across Tumors: Who to Test When
MinuteCE®
RAS Across Tumors: Who to Test When
Kathryn Arbour; Eileen M. O'Reilly, MD
0.75 program credits
- Kathryn Arbour
- Eileen M. O'Reilly, MD
0.75 program credits
Frontline Insights: Emerging Therapeutic Strategies in HNSCC
Frontline Insights: Emerging Therapeutic Strategies in HNSCC
CME/CE
Frontline Insights: Emerging Therapeutic Strategies in HNSCC
Kevin J Harrington, PhD, FRCP, FRCR, FRSB; Christophe Le Tourneau, MD, PhD
0.25 credits
- Kevin J Harrington, PhD, FRCP, FRCR, FRSB
- Christophe Le Tourneau, MD, PhD
0.25 credits
Breaking the Line: Moving Bispecific Antibodies Upstream in Treating Multiple Myeloma
Breaking the Line: Moving Bispecific Antibodies Upstream in Treating Multiple Myeloma
CME/CE
Breaking the Line: Moving Bispecific Antibodies Upstream in Treating Multiple Myeloma
María-Victoria Mateos, MD, PhD
0.25 credits
- María-Victoria Mateos, MD, PhD
0.25 credits
All Sides of the Joint: Integrated TGCT Care Across Specialties
All Sides of the Joint: Integrated TGCT Care Across Specialties
MinuteCE®
All Sides of the Joint: Integrated TGCT Care Across Specialties
A.J. Gelderblom, MD, PhD; Michiel van de Sande, MD, PhD
1.00 program credit
- A.J. Gelderblom, MD, PhD
- Michiel van de Sande, MD, PhD
- Chelsea Cole, MD
1.00 program credit
Unlocking the CSF1R Code: Targeted Pathways and Tailored Choices
Unlocking the CSF1R Code: Targeted Pathways and Tailored Choices
MinuteCE®
Unlocking the CSF1R Code: Targeted Pathways and Tailored Choices
A.J. Gelderblom, MD, PhD
1.00 program credit
- A.J. Gelderblom, MD, PhD
1.00 program credit
Clinical Evidence in Focus: Interpreting Data on Systemic Therapy Targeting CSF1R
Clinical Evidence in Focus: Interpreting Data on Systemic Therapy Targeting CSF1R
MinuteCE®
Clinical Evidence in Focus: Interpreting Data on Systemic Therapy Targeting CSF1R
A.J. Gelderblom, MD, PhD
1.00 program credit
- A.J. Gelderblom, MD, PhD
1.00 program credit
Patient Perspective: Navigating TGCT Treatment—Surgery vs Systemic Therapy
Patient Perspective: Navigating TGCT Treatment—Surgery vs Systemic Therapy
MinuteCE®
Patient Perspective: Navigating TGCT Treatment—Surgery vs Systemic Therapy
A.J. Gelderblom, MD, PhD
1.00 program credit
- A.J. Gelderblom, MD, PhD
1.00 program credit
The Safety Equation: Managing Adverse Events Associated With CSF1R Inhibitors in TGCT
The Safety Equation: Managing Adverse Events Associated With CSF1R Inhibitors in TGCT
MinuteCE®
The Safety Equation: Managing Adverse Events Associated With CSF1R Inhibitors in TGCT
A.J. Gelderblom, MD, PhD
1.00 program credit
- A.J. Gelderblom, MD, PhD
1.00 program credit
The Tumor That’s Not So Tiny: Understanding the Impact of TGCT
The Tumor That’s Not So Tiny: Understanding the Impact of TGCT
MinuteCE®
The Tumor That’s Not So Tiny: Understanding the Impact of TGCT
A.J. Gelderblom, MD, PhD
1.00 program credit
- A.J. Gelderblom, MD, PhD
1.00 program credit
Applying the Evidence: TGCT Treatment Insights for Sports Medicine Physicians
Applying the Evidence: TGCT Treatment Insights for Sports Medicine Physicians
MinuteCE®
Applying the Evidence: TGCT Treatment Insights for Sports Medicine Physicians
A.J. Gelderblom, MD, PhD; Chelsea Cole, MD
1.00 program credit
- A.J. Gelderblom, MD, PhD
- Chelsea Cole, MD
1.00 program credit
Surgical Crossroads: Practical Considerations for Optimizing Treatment in TGCT
Surgical Crossroads: Practical Considerations for Optimizing Treatment in TGCT
MinuteCE®
Surgical Crossroads: Practical Considerations for Optimizing Treatment in TGCT
A.J. Gelderblom, MD, PhD; Michiel van de Sande, MD, PhD
1.00 program credit
- A.J. Gelderblom, MD, PhD
- Michiel van de Sande, MD, PhD
1.00 program credit
MinuteCE®
Beyond the Joint: Cross-Specialty Solutions for Advancing TGCT Patient Care
A.J. Gelderblom, MD, PhD; Michiel van de Sande, MD, PhD
1.00 credit 10 episodes
- A.J. Gelderblom, MD, PhD
- Michiel van de Sande, MD, PhD
- Chelsea Cole, MD
1.00 credit 10 episodes
Beyond the Scalpel: When TGCT Surgery Isn’t the Solution
Beyond the Scalpel: When TGCT Surgery Isn’t the Solution
MinuteCE®
Beyond the Scalpel: When TGCT Surgery Isn’t the Solution
Michiel van de Sande, MD, PhD
1.00 program credit
- Michiel van de Sande, MD, PhD
1.00 program credit
Emerging Evidence in Focus: Interpreting Data on Next-Generation CSF1R TKIs
Emerging Evidence in Focus: Interpreting Data on Next-Generation CSF1R TKIs
MinuteCE®
Emerging Evidence in Focus: Interpreting Data on Next-Generation CSF1R TKIs
A.J. Gelderblom, MD, PhD
1.00 program credit
- A.J. Gelderblom, MD, PhD
1.00 program credit

5/10